Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2016 2
2017 5
2018 4
2019 8
2020 11
2021 10
2022 8
2023 6
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P, Inderberg EM, Wälchli S. Mensali N, et al. Among authors: inderberg em. Nat Commun. 2023 Jun 8;14(1):3375. doi: 10.1038/s41467-023-39097-x. Nat Commun. 2023. PMID: 37291203 Free PMC article.
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S. Caulier B, et al. Among authors: inderberg em. Cell Rep Med. 2024 Jun 18;5(6):101572. doi: 10.1016/j.xcrm.2024.101572. Epub 2024 May 15. Cell Rep Med. 2024. PMID: 38754420 Free PMC article.
Emerging Biomarkers for Immunotherapy in Glioblastoma.
Mensali N, Inderberg EM. Mensali N, et al. Among authors: inderberg em. Cancers (Basel). 2022 Apr 12;14(8):1940. doi: 10.3390/cancers14081940. Cancers (Basel). 2022. PMID: 35454848 Free PMC article. Review.
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Casey NP, Klee CH, Fåne A, Caulier B, Graczyk-Jarzynka A, Krawczyk M, Fidyt K, Josefsson SE, Köksal H, Dillard P, Patkowska E, Firczuk M, Smeland EB, Winiarska M, Myklebust JH, Inderberg EM, Wälchli S. Casey NP, et al. Among authors: inderberg em. J Biol Chem. 2023 Jul;299(7):104883. doi: 10.1016/j.jbc.2023.104883. Epub 2023 Jun 1. J Biol Chem. 2023. PMID: 37269947 Free PMC article.
Treating osteosarcoma with CAR T cells.
Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S. Köksal H, et al. Among authors: inderberg em. Scand J Immunol. 2019 Mar;89(3):e12741. doi: 10.1111/sji.12741. Epub 2019 Jan 15. Scand J Immunol. 2019. PMID: 30549299 Free article. Review.
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S. Casey NP, et al. Among authors: inderberg em. J Immunother Cancer. 2024 Apr 11;12(4):e008179. doi: 10.1136/jitc-2023-008179. J Immunother Cancer. 2024. PMID: 38604812 Free PMC article.
Combinatorial CAR design improves target restriction.
Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S. Köksal H, et al. Among authors: inderberg em. J Biol Chem. 2021 Jan-Jun;296:100116. doi: 10.1074/jbc.RA120.016234. Epub 2020 Dec 3. J Biol Chem. 2021. PMID: 33234592 Free PMC article.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk M, Prochorec-Sobieszek M, Winiarska M. Bobrowicz M, et al. Among authors: inderberg em. Oncoimmunology. 2024 Jun 4;13(1):2362454. doi: 10.1080/2162402X.2024.2362454. eCollection 2024. Oncoimmunology. 2024. PMID: 38846084 Free PMC article.
Sympathetic improvement of cancer vaccine efficacy.
Inderberg EM, Wälchli S. Inderberg EM, et al. Hum Vaccin Immunother. 2020 Aug 2;16(8):1888-1890. doi: 10.1080/21645515.2019.1703456. Epub 2020 Jan 24. Hum Vaccin Immunother. 2020. PMID: 31977269 Free PMC article.
A TCR-based Chimeric Antigen Receptor.
Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S. Walseng E, et al. Among authors: inderberg em. Sci Rep. 2017 Sep 6;7(1):10713. doi: 10.1038/s41598-017-11126-y. Sci Rep. 2017. PMID: 28878363 Free PMC article.
51 results